Literature DB >> 27189338

In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.

Zhenqiu Liu1,2,3, Yaying Lin4, Qi Lu1,2,3, Fang Li1,2,3, Jialin Yu5,6,7, Zhengli Wang1,2,3, Yu He1,2,3, Chao Song1,2,3.   

Abstract

PURPOSE: Refractory infection caused by bacterial biofilm is an important clinical problem. Pseudomonas aeruginosa is a common pathogen responsible for persistent and chronic biofilm infections. We aimed to explore the in vitro and in vivo activity of ethylenediamine tetraacetic acid (EDTA) in combination with antibacterial agents against mucoid P. aeruginosa biofilm.
METHODS: The minimal inhibitory concentration (MIC) and minimal bactericidal concentration of ciprofloxacin, gentamicin, and ampicillin alone or with EDTA against P. aeruginosa were determined in vitro. Extracellular polysaccharides (EPS) and structural parameters of the biofilm were monitored. P. aeruginosa was aerosolized and delivered into the lungs of guinea pigs, which were treated with ciprofloxacin with or without EDTA. The colony-forming units (CFUs) of P. aeruginosa were determined from the lungs.
RESULTS: EDTA reduced the MIC of ciprofloxacin and ampicillin by about 30-fold and that of gentamicin by twofold. EDTA reduced the biofilm EPS and the proportion of viable bacteria. The thickness, average diffusion distance, and textural entropy of EDTA-treated biofilm were significantly decreased. EDTA plus antibiotics reduced the colony counting from 107 to 103 CFU/mL. In vivo, EDTA plus ciprofloxacin had a significantly lower mean CFU/g of lung tissue (EDTA + ciprofloxacin 1.3 ± 0.19; EDTA 4.4 ± 0.57; ciprofloxacin 4.2 ± 0.47), and lung lesions were less severe compared with the single treatment groups.
CONCLUSIONS: EDTA can destroy the biofilm structures of mucoid P. aeruginosa in vitro. Moreover, EDTA and ciprofloxacin had a significant bactericidal effect against biofilm in vivo.

Entities:  

Keywords:  Antibacterial agents; Biofilm; Ethylenediamine tetraacetic acid; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2016        PMID: 27189338     DOI: 10.1007/s15010-016-0905-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  37 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Quantifying biofilm structure: facts and fiction.

Authors:  Haluk Beyenal; Zbigniew Lewandowski; Gary Harkin
Journal:  Biofouling       Date:  2004-02       Impact factor: 3.209

3.  Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.

Authors:  A M Farca; G Piromalli; F Maffei; G Re
Journal:  J Small Anim Pract       Date:  1997-06       Impact factor: 1.522

4.  Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms.

Authors:  S Sarkisova; M A Patrauchan; D Berglund; D E Nivens; M J Franklin
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.

Authors:  Ray Hachem; Paul Bahna; Hend Hanna; L Clifton Stephens; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.

Authors:  Ashwini Chauhan; David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

7.  In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.

Authors:  David Lebeaux; Véronique Leflon-Guibout; Jean-Marc Ghigo; Christophe Beloin
Journal:  J Antimicrob Chemother       Date:  2015-02-23       Impact factor: 5.790

8.  Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria.

Authors:  R E Wooley; M S Jones
Journal:  Vet Microbiol       Date:  1983-06       Impact factor: 3.293

Review 9.  Invasiveness and intracellular growth of Listeria monocytogenes.

Authors:  P Berche; J L Gaillard; S Richard
Journal:  Infection       Date:  1988       Impact factor: 3.553

10.  Effect of EDTA on Salmonella enterica serovar Typhimurium involves a component not assignable to lipopolysaccharide release.

Authors:  H-L Alakomi; M Saarela; I M Helander
Journal:  Microbiology       Date:  2003-08       Impact factor: 2.777

View more
  10 in total

Review 1.  Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review.

Authors:  Samuel J M Hale; Brett Wagner Mackenzie; Christian A Lux; Kristi Biswas; Raymond Kim; Richard G Douglas
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.

Authors:  Giuseppantonio Maisetta; Lucia Grassi; Semih Esin; Ilaria Serra; Mariano A Scorciapino; Andrea C Rinaldi; Giovanna Batoni
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

Review 3.  Approaches to Dispersing Medical Biofilms.

Authors:  Derek Fleming; Kendra P Rumbaugh
Journal:  Microorganisms       Date:  2017-04-01

4.  Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP.

Authors:  Chee-Seng Hee; Judith Habazettl; Christoph Schmutz; Tilman Schirmer; Urs Jenal; Stephan Grzesiek
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-01       Impact factor: 11.205

5.  AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.

Authors:  Amy L Bogue; Warunya Panmanee; Cameron T McDaniel; Joel E Mortensen; Edwin Kamau; Luis A Actis; Jay A Johannigman; Michael J Schurr; Latha Satish; Nalinikanth Kotagiri; Daniel J Hassett
Journal:  PLoS One       Date:  2021-03-03       Impact factor: 3.240

6.  EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence In Vitro-Impairment of Secretory Profile and Biofilm Production onto Peritoneal Dialysis Catheters.

Authors:  Bruna Colombari; Gaetano Alfano; Christian Gamberini; Gianni Cappelli; Elisabetta Blasi
Journal:  Microbiol Spectr       Date:  2021-11-17

Review 7.  Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections.

Authors:  Krystle A Blanchette; Joseph C Wenke
Journal:  J Bone Jt Infect       Date:  2018-04-12

8.  Targeting Pseudomonas aeruginosa in the Sputum of Primary Ciliary Dyskinesia Patients with a Combinatorial Strategy Having Antibacterial and Anti-Virulence Potential.

Authors:  Giuseppantonio Maisetta; Lucia Grassi; Semih Esin; Esingül Kaya; Andrea Morelli; Dario Puppi; Martina Piras; Federica Chiellini; Massimo Pifferi; Giovanna Batoni
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

Review 9.  Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections.

Authors:  Víctor Vinuesa; Michael J McConnell
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

10.  AB569, a Novel, Topical Bactericidal Gel Formulation, Kills Pseudomonas aeruginosa and Promotes Wound Healing in a Murine Model of Burn Wound Infection.

Authors:  Amanda Barry; Warunya Panmanee; Daniel J Hassett; Latha Satish
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.